Concepedia

Shaokun Pang

SP

Statistics

Publications

21

Citations

1.2K

H-Index

19

Active since

1999

Affiliations

National Institute on Drug Abuse(Current)

National Institutes of Health

Bristol-Myers Squibb (United States)

Swedish National Board of Forensic Medicine

Bristol-Myers Squibb (Germany)

Shaokun Pang is an author at National Institute on Drug Abuse specializing in pharmacology, drug metabolism, and medicine.

Publications per year

1999–2022

21

Publications

21

Metabolism of synthetic cannabinoids PB-22 and its 5-fluoro analog, 5F-PB-22, by human hepatocyte incubation and high-resolution mass spectrometry

Ariane Wohlfarth, Adarsh Gandhi, Shaokun Pang et al. · Analytical and Bioanalytical Chemistry · 2014 · 105 citations

, , +13

Pentylindole/Pentylindazole Synthetic Cannabinoids and Their 5-Fluoro Analogs Produce Different Primary Metabolites: Metabolite Profiling for AB-PINACA and 5F-AB-PINACA

Ariane Wohlfarth, Marisol S. Castaneto, Mingshe Zhu et al. · The AAPS Journal · 2015 · 104 citations · Full text

, , +8

Etoposide Metabolites Enhance DNA Topoisomerase II Cleavage near Leukemia-Associated <i>MLL</i> Translocation Breakpoints

Brian D. Lovett, Dirk Strumberg, Ian A. Blair et al. · Biochemistry · 2001 · 89 citations

, , +16

First Metabolic Profile of XLR-11, a Novel Synthetic Cannabinoid, Obtained by Using Human Hepatocytes and High-Resolution Mass Spectrometry

Ariane Wohlfarth, Shaokun Pang, Mingshe Zhu et al. · Clinical Chemistry · 2013 · 89 citations

, , +9

Metabolism of Carfentanil, an Ultra-Potent Opioid, in Human Liver Microsomes and Human Hepatocytes by High-Resolution Mass Spectrometry

Michael G. Feasel, Ariane Wohlfarth, J. Michael Nilles et al. · The AAPS Journal · 2016 · 89 citations

, , +17

1–5 of 21